Health Canada Approves Roflumilast Cream 0.15% (Zoryve, Arcutis) for AD

Health Canada has approved roflumilast cream 0.15% (Zoryve, Arcutis) for the treatment of mild-to-moderate atopic dermatitis (AD) in adults and children aged 6 and up.
health-check
domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init
action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /dom76025/wp-includes/functions.php on line 6121Health Canada has approved roflumilast cream 0.15% (Zoryve, Arcutis) for the treatment of mild-to-moderate atopic dermatitis (AD) in adults and children aged 6 and up.